Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis
Key Highlights
- ➤Nutriband (NTRB) CEO featured in Nick Shirley documentary about America’s opioid crisis
- ➤AVERSA™ platform incorporates aversive agents into transdermal patches to deter abuse
- ➤Lead product is an abuse-deterrent fentanyl patch under development
- ➤AVERSA™ technology holds patents across the United States and multiple international markets
Expert Statements
Gareth Sheridan, CEO of Nutriband
“The opioid crisis isn't an abstraction — it's a daily reality for families across this country, on both sides of addiction and genuine pain, and it demands real solutions.”
Gareth Sheridan, CEO of Nutriband
“I was glad to work with Nick and speak plainly about where pharmaceutical innovation fits into that fight. AVERSA™ was built specifically to address this problem: giving patients who need these medications access to them, while making them fundamentally harder to abuse, misuse, or divert for people suffering from addiction or from accidental exposure.”
ORLANDO, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that its CEO, Gareth Sheridan, has been featured in a new documentary by independent journalist and filmmaker Nick Shirley examining the ongoing opioid crisis in the United States. Shirley, turns his lens in this latest piece to the devastating impact of illegal opioid abuse on individuals and communities across the country — and the complex challenges surrounding some of the nation's most commonly abused prescription medications.
Sheridan participated in the documentary to bring a pharmaceutical innovation perspective to the conversation, discussing how technologies such as Nutriband's AVERSA™ abuse-deterrent platform are designed to help reduce the risk of abuse, misuse, diversion, and accidental exposure associated with high-risk medications — while working to preserve access for the patients who depend on them for legitimate medical need.
Get started
Create a free account to read the full story.